600513 Jiangsu Lianhuan Pharmaceutical
- 8.18
- +0.02+0.25%
Jiangsu Lianhuan Pharmaceutical News
Lianhuan Pharmaceutical\'s announcement on the company\'s selection as a national specialized, special and new “little giant” enterprise
Lianhuan Pharmaceutical\'s announcement that the company has passed the US FDA on-site inspection
Lianhuan Pharmaceutical\'s “Articles of Association” (third revision in 2024)
Announcement of Lianhuan Pharmaceutical on amending the “Articles of Association” and its annexes
Notice of Lianhuan Pharmaceutical on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Jiangsu Lianhuan Pharmaceutical: Announcement from Jiangsu Lianhuan Pharmaceutical regarding the risk warning and mitigation measures, as well as relevant commitments from specific parties, for the dilutive immediate return of stocks issued to specific targets via simplified procedures in 2024.
Jiangsu Lianhuan Pharmaceutical's announcement regarding the approval of the application for the listing of chemical raw materials as active pharmaceutical ingredients.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Lianhuan Pharmaceutical
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on Lianhuan Pharmaceutical's 2024 First Extraordinary General Meeting of Shareholders
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Lianhuan Pharmaceutical
Notice of Lianhuan Pharmaceutical on Convening the First Extraordinary General Meeting of Shareholders in 2024
Announcement of Resolutions of Lianhuan Pharmaceutical\'s 2023 Annual General Meeting of Shareholders
Legal Opinion on Lianhuan Pharmaceutical\'s 2023 Annual General Meeting of Shareholders
Lianhuan Pharmaceutical's 2023 Annual General Meeting of Shareholders Meeting Materials
Lianhuan Pharmaceutical's Announcement on Additional Provisional Proposals for the 2023 Annual General Meeting of Shareholders
Announcement of Lianhuan Pharmaceutical on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to issuing shares to specific targets through simplified procedures
Announcement of Lianhuan Pharmaceutical on amending the “Articles of Association”
Lianhuan Pharmaceutical's “Articles of Association” (second revision in 2024)
Report of the Audit Committee of the Board of Directors of Lianhuan Pharmaceutical on the evaluation of the accounting firm's performance in 2023 and the performance of supervisory duties
Lianhuan Pharmaceutical Accountants Service Selection and Employment System
Analysis
Price Target
No Data
